Advertisement
Screener

TSCAN THERAPEUTICS, INC. (TCRX) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3

2.6 / 5 stars · 19/37 Roast Me

TSCAN THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3

TSCAN THERAPEUTICS, INC. (TCRX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Notes › Fair Value Disclosures › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2026-08-12

  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2026-06-30 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2026-03-31 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-12-31 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-09-30 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2024 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2023 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2022 was $0.00.
  • TSCAN THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2021 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$0.00
10-Q · filed 2026-08-12
$0.00
derived: sum of 3 quarters · filed 2026-08-12
$0.00
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$0.00
10-Q · filed 2026-05-06
$0.00
derived: sum of 2 quarters · filed 2026-08-12
$0.00
derived: sum of 3 quarters · filed 2026-08-12
$0.00
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$0.00
derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-12
$0.00
derived: sum of 2 quarters · filed 2026-08-12
$0.00
derived: sum of 3 quarters · filed 2026-08-12
$0.00
10-Q · filed 2026-08-12
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$0.00
derived: sum of 2 quarters · filed 2025-11-12
$0.00
10-Q · filed 2025-11-12
$0.00
derived: sum of 4 quarters · filed 2026-03-04
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$0.00
10-Q · filed 2025-08-12
$0.00
derived: sum of 3 quarters · filed 2026-03-04
$0.00
derived: sum of 4 quarters · filed 2026-03-04
2025-03-31$0.00
10-Q · filed 2025-05-06
$0.00
derived: sum of 2 quarters · filed 2026-03-04
$0.00
derived: sum of 3 quarters · filed 2026-03-04
$0.00
derived: sum of 4 quarters · filed 2026-03-04
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$0.00
derived: sum of 2 quarters · filed 2026-03-04
$0.00
derived: sum of 3 quarters · filed 2026-03-04
$0.00
10-K · filed 2026-03-04
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 4 quarters · filed 2025-03-05
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
$0.00
10-Q · filed 2024-08-12
$0.00
derived: sum of 3 quarters · filed 2025-03-05
$0.00
derived: sum of 4 quarters · filed 2025-03-05
2024-03-31$0.00
10-Q · filed 2024-05-13
$0.00
derived: sum of 2 quarters · filed 2025-03-05
$0.00
derived: sum of 3 quarters · filed 2025-03-05
$0.00
derived: sum of 4 quarters · filed 2025-03-05
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$0.00
derived: sum of 2 quarters · filed 2025-03-05
$0.00
derived: sum of 3 quarters · filed 2025-03-05
$0.00
10-K · filed 2025-03-05
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$0.00
derived: sum of 2 quarters · filed 2023-11-09
$0.00
10-Q · filed 2023-11-09
$0.00
derived: sum of 4 quarters · filed 2024-03-06
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$0.00
10-Q · filed 2023-08-10
$0.00
derived: sum of 3 quarters · filed 2024-03-06
$0.00
derived: sum of 4 quarters · filed 2024-03-06
2023-03-31$0.00
10-Q · filed 2023-05-10
$0.00
derived: sum of 2 quarters · filed 2024-03-06
$0.00
derived: sum of 3 quarters · filed 2024-03-06
$0.00
derived: sum of 4 quarters · filed 2024-03-06
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
$0.00
derived: sum of 2 quarters · filed 2024-03-06
$0.00
derived: sum of 3 quarters · filed 2024-03-06
$0.00
10-K · filed 2024-03-06
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
$0.00
derived: sum of 4 quarters · filed 2023-03-08
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$0.00
10-Q · filed 2022-08-10
$0.00
derived: sum of 3 quarters · filed 2023-03-08
$0.00
derived: sum of 4 quarters · filed 2023-03-08
2022-03-31$0.00
10-Q · filed 2022-05-12
$0.00
derived: sum of 2 quarters · filed 2023-03-08
$0.00
derived: sum of 3 quarters · filed 2023-03-08
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$0.00
derived: sum of 2 quarters · filed 2023-03-08
$0.00
10-K · filed 2023-03-08
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$0.00
10-Q · filed 2021-11-10
2021-06-30$0.00
10-Q · filed 2021-08-19
2020-12-31$0.00
10-K · filed 2022-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
IN8BIO, INC. (INAB)United States$0.012B-0.76
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B